Cargando…
Recent advances and novel agents for gastrointestinal stromal tumor (GIST)
The discovery of CD117 mutation in almost all gastrointestinal stromal tumors (GISTs) marked a milestone. Other spindle cell neoplasms arising from the GI tract including lipoma, schwannoma, hemangioma, leiomyoma, and leiomyosarcoma are typically CD117-negative. GIST research and clinical care now r...
Autores principales: | Lamba, Gurpreet, Ambrale, Samir, Lee, Byung, Gupta, Ridhi, Rafiyath, Shamudheen M, Liu, Delong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3405472/ https://www.ncbi.nlm.nih.gov/pubmed/22569033 http://dx.doi.org/10.1186/1756-8722-5-21 |
Ejemplares similares
-
Current management and prognostic features for gastrointestinal stromal tumor (GIST)
por: Lamba, Gurpreet, et al.
Publicado: (2012) -
Comparison of safety and toxicity of liposomal doxorubicin vs. conventional anthracyclines: a meta-analysis
por: Rafiyath, Shamudheen M, et al.
Publicado: (2012) -
First-line treatment for chronic myeloid leukemia: dasatinib, nilotinib, or imatinib
por: Wei, Guoqing, et al.
Publicado: (2010) -
Primary omental Gastrointestinal stromal tumor (GIST)
por: Todoroki, Takeshi, et al.
Publicado: (2007) -
LAPAROSCOPIC RESECTION OF GASTROINTESTINAL STROMAL TUMORS (GIST)
por: LOUREIRO, Marcelo de Paula, et al.
Publicado: (2016)